(-0.46%) 5 048.42 points
(-0.98%) 38 086 points
(-0.64%) 15 612 points
(0.34%) $83.85
(-2.20%) $1.602
(-0.03%) $2 341.80
(0.17%) $27.40
(0.91%) $928.90
(0.05%) $0.932
(0.11%) $10.96
(0.04%) $0.800
(0.02%) $92.18
Live Chart Being Loaded With Signals
EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise...
Stats | |
---|---|
Today's Volume | 646 116 |
Average Volume | 929 131 |
Market Cap | 1.23B |
EPS | £0 ( 2023-09-06 ) |
Next earnings date | ( £0 ) 2024-05-23 |
Last Dividend | £21.10 ( 2023-06-15 ) |
Next Dividend | £0 ( N/A ) |
P/E | 40.89 |
ATR14 | £9.82 (0.51%) |
Volume Correlation
EMIS Group PLC Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
EMIS Group PLC Correlation - Currency/Commodity
EMIS Group PLC Financials
Annual | 2022 |
Revenue: | £175.37M |
Gross Profit: | £162.47M (92.64 %) |
EPS: | £0.530 |
Q2 | 2019 |
Revenue: | £39.88M |
Gross Profit: | £36.03M (90.34 %) |
EPS: | £0.0900 |
Q1 | 2019 |
Revenue: | £39.88M |
Gross Profit: | £36.03M (90.34 %) |
EPS: | £0.0900 |
Q1 | 2019 |
Revenue: | £39.88M |
Gross Profit: | £36.03M (90.34 %) |
EPS: | £0.0900 |
Financial Reports:
No articles found.
EMIS Group PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£17.60 (N/A) |
£0 (N/A) |
£21.10 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £5.60 | 2010-09-22 |
Last Dividend | £21.10 | 2023-06-15 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 27 | -- |
Total Paid Out | £308.10 | -- |
Avg. Dividend % Per Year | 1.42% | -- |
Score | 4.57 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.22 | |
Div. Directional Score | 9.09 | -- |
Year | Amount | Yield |
---|---|---|
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £27.10 | 3.18% |
2019 | £29.80 | 3.24% |
2020 | £31.60 | 2.82% |
2021 | £33.60 | 3.03% |
2022 | £35.20 | 2.65% |
2023 | £21.10 | 1.13% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SHG.L | Dividend Knight | 2023-11-02 | Semi-Annually | 4 | 0.91% | |
ING.L | Dividend Knight | 2023-09-21 | Annually | 32 | 2.29% | |
BRBY.L | Dividend Knight | 2023-06-29 | Annually | 22 | 1.53% | |
ORIT.L | Dividend Knight | 2023-08-17 | Quarterly | 5 | 2.77% | |
FEN.L | Ex Dividend Knight | 2023-10-05 | Annually | 13 | 1.04% | |
0KEZ.L | Dividend Junior | 2023-09-22 | Sporadic | 7 | 0.78% | |
STAN.L | Dividend Junior | 2023-08-10 | Annually | 32 | 1.92% | |
KGF.L | Dividend Knight | 2023-10-12 | Annually | 32 | 2.25% | |
CER.L | Dividend Knight | 2023-06-01 | Semi-Annually | 9 | 0.75% | |
PSHD.L | No Dividend Player | 2023-08-17 | Annually | 6 | 0.41% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.189 | 1.500 | 6.22 | 9.33 | [0 - 0.5] |
returnOnAssetsTTM | 0.148 | 1.200 | 5.08 | 6.10 | [0 - 0.3] |
returnOnEquityTTM | 0.245 | 1.500 | 8.39 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.669 | -1.000 | 3.31 | -3.31 | [0 - 1] |
currentRatioTTM | 1.210 | 0.800 | 8.95 | 7.16 | [1 - 3] |
quickRatioTTM | 0.649 | 0.800 | -0.887 | -0.709 | [0.8 - 2.5] |
cashRatioTTM | 0.649 | 1.500 | 7.50 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0194 | -1.500 | 9.68 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 52.25 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.722 | 2.00 | 9.76 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.611 | 2.00 | 9.69 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0306 | -1.500 | 9.88 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.926 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.158 | 1.000 | 8.84 | 8.84 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 10.59 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.780 | 0.800 | 8.13 | 6.51 | [0.5 - 2] |
Total Score | 12.95 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 37.07 | 1.000 | 6.36 | 0 | [1 - 100] |
returnOnEquityTTM | 0.245 | 2.50 | 8.97 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.611 | 2.00 | 9.80 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.21 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.722 | 2.00 | 9.76 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.669 | 1.500 | 3.31 | -3.31 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.263 | 1.000 | 5.91 | 0 | [0.1 - 0.5] |
Total Score | 5.22 |
EMIS Group PLC
EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web, which enables patients to order repeat medication online and track progress from order to home delivery; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators